Marktprognose für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)
Wachsende wirtschaftliche Belastung durch Krebs treibt den Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika an
Laut der Weltgesundheitsorganisation (WHO) ist Krebs eine der häufigsten Todesursachen weltweit und war im Jahr 2020 für etwa 10 Millionen Todesfälle verantwortlich. Laut der Internationalen Agentur für Krebsforschung wird die globale Krebsbelastung bis 2040 wahrscheinlich um 30,2 Millionen zusätzliche Fälle zunehmen. Laut der Brustkrebsorganisation sind etwa 5–10 % der Brustkrebsfälle weltweit erblich bedingt und werden durch abnormale Gene verursacht, die von Generation zu Generation weitergegeben werden. Laut dem Artikel „Lifestyle, Genetic Risk and Incidence of Cancer“, der 2023 im International Journal of Epidemiology veröffentlicht wurde, sind fast 33 % der auftretenden Krebserkrankungen erblich bedingt, und das Risiko genetischer Mutationen ist bei dieser Krankheit hoch. Daher entscheiden sich die Menschen für eine genetische Profilierung zur Früherkennung und personalisierten Behandlung von erblich bedingten Krebsfällen. BRCA1 und BRCA2 werden manchmal als Tumorsuppressorgene bezeichnet. Menschen, die die schädlichen Varianten eines dieser Gene erben, haben ein höheres Risiko für verschiedene Krebsarten, insbesondere Brust- und Eierstockkrebs. Diese Menschen neigen auch dazu, in jüngeren Jahren an Krebs zu erkranken als Menschen, die keine Variationen in den genannten Genen aufweisen. Studien, die sich auf die Verarbeitung von Nukleinsäure durch Krebszellen konzentrieren, werden wahrscheinlich dazu beitragen, den Krebsstoffwechsel zu verstehen. DNA wird typischerweise in ein virales oder nicht-virales Partikel verpackt, um in die zu transfizierende Zelle übertragen zu werden. Der Gentransfer wurde als neuer Ansatz vorgeschlagen, um die Wirksamkeit von Antitumormedikamenten bei der Behandlung hartnäckiger oder metastasierter Krebserkrankungen zu verbessern. Die Kombination von Gentherapie und Medikamenten (ähnliche Therapie) soll die antiproliferativen Effekte klassischer Behandlungen bei Lungen-, Dickdarm-, Bauchspeicheldrüsen-, Blasen- und Brustkrebs verstärken. Die steigende wirtschaftliche Belastung durch Krebs stärkt somit den Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika.
Marktübersicht für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika
Die Region Süd- und Mittelamerika ist in Brasilien, Argentinien und den Rest von Süd- und Mittelamerika unterteilt. Brasilien hält im Jahr 2022 mehr als die Hälfte des regionalen Anteils.
Brasilien hat aufgrund seiner günstigen Wirtschaftspolitik und Reformen, einer soliden Position in der inländischen Arzneimittelproduktion und erhöhten Gesundheitsausgaben bedeutende Entwicklungen in der Pharmaindustrie gemacht. Laut der International Trade Administration (ITA) ist Brasilien der größte Gesundheitsmarkt in Lateinamerika und gibt 9,1 % seines BIP für das Gesundheitswesen aus. Inländische Unternehmen dominieren die Gesamtproduktion pharmazeutischer Produkte im Land und ermöglichen so seine Handelsaktivitäten. Laut dem US-Handelsministerium machen inländische Unternehmen etwa 80 % aller Pharmaunternehmen in Brasilien aus. Somit ist die wachsende Pharmaindustrie einer der Hauptfaktoren für das Wachstum des Marktes für Transfektionsreagenzien und -geräte in Brasilien.
Außerdem hat Argentinien nach Brasilien die größte Pharmaindustrie in Süd- und Mittelamerika. Das Wachstum des Marktes für Transfektionsreagenzien und -geräte im Land wird weitgehend durch umfangreiche Forschungs- und Entwicklungsanstrengungen und eine wachsende inländische Produktion von Arzneimitteln vorangetrieben. Die wachsende Nachfrage nach pharmazeutischen und biopharmazeutischen Produkten aufgrund zunehmender Unsicherheiten hinsichtlich der Gesundheitsbedingungen, eines zunehmend strengeren regulatorischen Umfelds für die Pharmaindustrie und einer verbesserten Logistik der Rohstoffe werden das Wachstum des Marktes für Transfektionsreagenzien und -geräte in Argentinien im Prognosezeitraum wahrscheinlich begünstigen.
Umsatz und Prognose des Marktes für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika bis 2030 (Mio. USD)
Segmentierung des Marktes für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika
Der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.
Basierend auf dem Produkt ist der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.
In Bezug auf die Methode ist der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika in virale Methoden, nicht-virale Methoden und Hybridmethoden segmentiert. Das Segment nicht-virale Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Auch das Segment der chemischen Methoden ist in liposomale/lipidreiche und nicht-liposomale/lipidreiche Methoden unterteilt.
Nach Anwendung ist der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika in biomedizinische Forschung, Proteinproduktion und therapeutische Verabreichung unterteilt. Das Segment der biomedizinischen Forschung hatte 2022 den größten Anteil.
Basierend auf dem Endverbraucher ist der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika in akademische und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment der Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.
Nach Ländern wird der Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika in Brasilien, Argentinien und den Rest von Süd- und Mittelamerika unterteilt. Brasilien dominierte 2022 den Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG und MaxCyte Inc sind einige der führenden Unternehmen auf dem Markt für Transfektionsreagenzien und -geräte in Süd- und Mittelamerika.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 South & Central America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - South & Central America Market Analysis
5.1 South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
6. South & Central America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market -Country Analysis
10.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Brazil: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Brazil: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Argentina: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Argentina: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. South & Central America Transfection Reagents and Equipment Market Segmentation
Table 2. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. South & Central America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. South & Central America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. South & Central America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. South & Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Brazil: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Argentina: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of South & Central America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in South & Central America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.